Cargando…
The impact of implantable cardioverter defibrillator on the prognosis of nonischemic dilated cardiomyopathy patients compared with standard medical treatments
BACKGROUND: Patients with nonischemic dilated cardiomyopathy (DCM) are susceptible to arrhythmias and implantable cardioverter defibrillator (ICD) in addition to medical treatments may help prevent sudden cardiac death (SCD) and improve survival in this population. HYPOTHESIS: We aim to investigate...
Autores principales: | Salehi Omran, Hossein, Naghashzadeh, Farah, Irilouzadian, Rana, Dolatshahi, Sina, Hedayati Goudarzi, Mohammad Taghi, Salehi Omran, Mohammad Taghi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10270273/ https://www.ncbi.nlm.nih.gov/pubmed/37057368 http://dx.doi.org/10.1002/clc.24022 |
Ejemplares similares
-
Response: Impact of implantable cardioverter defibrillator on survival in patients with nonischemic dilated cardiomyopathy
por: Salehi Omran, Hossein, et al.
Publicado: (2023) -
Implantable cardioverter defibrillator in nonischemic cardiomyopathy: A systematic review and meta‐analysis
por: Khan, Safi U., et al.
Publicado: (2017) -
Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with implantable cardioverter-defibrillators with ischemic cardiomyopathy versus nonischemic cardiomyopathy at 33-month follow-up
por: Gandhi, Kaushang, et al.
Publicado: (2010) -
Fatal association of COVID‐19 and acute type A aortic dissection
por: Irilouzadian, Rana, et al.
Publicado: (2022) -
Overweight and obesity as protective factors against mortality in nonischemic cardiomyopathy patients with an implantable cardioverter defibrillator
por: Zhou, Bin, et al.
Publicado: (2020)